PTV Healthcare Capital Launches New Podcast Series

‘TOP Talks’ to discuss entrepreneurs and the changing healthcare landscape

Austin, Texas – January 15, 2015 – PTV Healthcare Capital, a venture capital and growth equity firm, today launched a new podcast series, TOP Talks. The podcast will feature a series of conversations between PTV Managing Director Rick Anderson and various guest speakers, including PTV Senior Advisors and other industry thought leaders as they discuss the changing landscape of the healthcare industry and what that means for healthcare entrepreneurs.

The first podcast of the new series features Chas McKhann, a Director in Life Sciences at Monitor Deloitte, the strategy consulting practice of Deloitte Consulting, LLP.  McKhann and his colleagues help medical technology companies develop and execute growth strategies to thrive in the changing global healthcare marketplace. McKhann’s areas of expertise include global commercialization strategies, customer analytics and segmentation, marketing excellence, product launches, and sales force organization & effectiveness.

McKhann’s experience includes a distinctive combination of more than 10 years as a strategy consultant and more than 10 years in executive leadership roles at prominent medical technology companies.  McKhann’s prior executive leadership roles include: WW VP of Marketing for the $2.5 billion Cardiac Rhythm Management division at Boston Scientific, General Manager for a $200 million franchise at Guidant, and Director of Marketing at Johnson & Johnson where he oversaw the launch of the CYPHER® drug eluting stent.  Prior to joining Deloitte, McKhann was CEO of a VC-funded medical device start-up company.

In their TOP Talk, Anderson and McKhann discuss innovation in the changing healthcare landscape, including the importance of considering the patient experience and the role of big data. McKhann addresses the necessity of what he calls the “triple aim in healthcare”: improving outcomes, improving patient experiences, and improving costs. But he stresses that new entrepreneurs entering the healthcare space must do so with a lens on how they are going to deliver value to the healthcare system as a whole. “It’s important to have an innovative technology, but you’ve got to think about innovation more broadly,” says McKhann.  “You’ve got to think about what am I delivering, how am I going to deliver it, and how am I going to improve outcomes and do it in a cost efficient way, and you’ve got to think about that early. And if you do that, then you’ve got a home run.”

“We couldn’t agree with Chas more that the changing marketplace is creating extraordinary opportunities for entrepreneurs,” said PTV Managing Director Rick Anderson. “The TOP Talks podcast series is aimed towards highlighting these opportunities for healthcare entrepreneurs. It is our goal to add value beyond the capital we invest.”

PTV also today launched the second video in their new video series, Advice from the TOP. The video features Dennis McWilliams, Apollo Endosurgery Founder and Chief Commercial Officer,  as he discusses his experiences partnering with PTV. The Advice from the TOP series, which launched in December of last year, features PTV CEOs and Senior Advisors as well as other industry thought leaders offering insight and advice to entrepreneurs in the healthcare industry and reflecting on their experiences partnering with PTV.

Both Advice from the TOP and TOP Talks can be found online on PTV’s website.

PTV Managing Director Rick Anderson (L) discusses the changing healthcare landscape with Monitor Deloitte Director Chas McKhann


About PTV

PTV is a healthcare venture capital and growth equity firm dedicated to enabling healthcare entrepreneurs and global innovation. It is comprised of a highly collaborative team of professionals, deeply experienced as investors and operators of life science companies. PTV focuses on mid-to-late stage companies with comparatively low technical, regulatory, and financial risk that are “with the grain” of healthcare economics – improving patient outcomes while decreasing costs – in markets with significant unmet clinical needs.


Alexa Bourdage